MétaCan
Menu
Back to cohort
Record W4411787032 · doi:10.1093/ibd/izaf136

Evaluation and Management of Glucocorticoid-Induced Adrenal Insufficiency in IBD: An Expert Opinion

2025· article· en· W4411787032 on OpenAlexaff
Cindy C Y Law, Rachel Sheskier, Natalia Viera-Feliciano, Andrea Delgado-Nieves, Shivani Seth, Jurij Hanžel, Christopher Ma, Jean‐Frédéric Colombel, Alice C. Levine, Elizabeth A. Spencer, Virginia Solitano, Vaibhaw Kumar, Remo Panaccione, Bruce E Sands, Laurent Peyrin-Biroulet, Silvio Danese, Geert D’Haens, Raja Atreya, Matthieu Allez, Charles N. Bernstein, Peter Bossuyt, Brian Bressler, Robert V. Bryant, Benjamin L. Cohen, Ferdinando D’Amico, Axel Dignaß, Marla Dubinsky, Phillip Fleshner, Richard B. Gearry, Stephen B. Hanauer, Ailsa Hart, Maia Kayal, Torsten Kucharzik, Péter L. Lakatos, Édouard Louis, Fernando Magro, Neeraj Narula, Rupert W. Leong, Julián Panés, Tim Raine, Zhihua Ran, Miguel Regueiro, Walter Reinsch, Siddharth Singh, A. Hillary Steinhart, Simon Travis, Ryan C. Ungaro, Takayuki Yamamoto, David T. Rubin, Parambir S. Dulai, Linda J. Cornfield, Malcolm Hogan, William J. Sandborn, Brian G. Feagan, Vipul Jairath

Bibliographic record

VenueInflammatory Bowel Diseases · 2025
Typearticle
Languageen
FieldMedicine
TopicAdrenal Hormones and Disorders
Canadian institutionsUniversity of Calgary
Fundersnot available
KeywordsGlucocorticoidMedicineAdrenal insufficiencyDelphi methodPrednisoneExpert opinionInflammatory bowel diseaseIntensive care medicineInternal medicineDisease

Abstract

fetched live from OpenAlex

BACKGROUND AND AIMS: Glucocorticoid-induced adrenal insufficiency (GC-AI) is a potentially life-threatening side effect of glucocorticoid therapy. Currently, there is no consensus on monitoring and treating GC-AI in inflammatory bowel disease (IBD) patients. This systematic review and meta-analysis aimed to determine the prevalence of GC-AI in IBD patients following glucocorticoid use. Additionally, a Delphi panel was conducted to develop evidence-based expert opinions on evaluating and managing GC-AI in IBD patients. METHODS: Thirty-four articles were included in this study. Of these, 26 articles reported the prevalence of GC-AI in IBD patients. Statements were generated and rated by a panel of adult and pediatric gastroenterologists using a 1-9 scale. Statements were classified as inappropriate, uncertain, or appropriate based on the median panel rating and the degree of disagreement. RESULTS: The prevalence of GC-AI across all studies was 26.9% (95% CI: 18.9-36.8, I2: 96%). The panel emphasized the importance of maintaining a high suspicion for GC-AI in IBD patients treated with systemic glucocorticoids and considering risk factors such as exogenous glucocorticoid use ≥4 weeks at doses ≥5 mg of prednisone-equivalent. Recommendations for initial screening and management of GC-AI are provided. The management of GC-AI in special populations, such as those in the perioperative setting is also addressed. The panel underscored the need to consider GC-AI assessment in clinical trial design. CONCLUSIONS: GC-AI is a serious, often underrecognized side effect of glucocorticoid use. This study presents expert opinions on the evaluation and management of GC-AI in IBD patients, emphasizing the need for vigilance and appropriate management strategies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.293
Threshold uncertainty score0.453

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.328
Teacher spread0.305 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueInflammatory Bowel DiseasesSame topicAdrenal Hormones and DisordersFrench-language works237,207